Teza Capital Management LLC Bristol Myers Squibb CO Transaction History

Teza Capital Management LLC

$904 Million
Q3 2024

A detailed history of Teza Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Teza Capital Management LLC holds 56,826 shares of BMY stock, worth $3.28 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

56,826

Previous 66,067 13.99%

Holding current value

$3.28 Million

Previous $2.74 Million 7.18%

% of portfolio

0.33%

Previous 0.34%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $366,498 - $478,221	-9,241 Reduced 13.99%	56,826 $2.94 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $2.66 Million - $3.5 Million	66,067 New	66,067 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $726,181 - $866,535	14,979 Added 106.67%	29,021 $1.49 Million
Q3 2023 Feb 22, 2024	SELL	$57.89 - $64.73 $1.68 Million - $1.88 Million	-29,018 Reduced 71.57%	11,525 $668,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $2.53 Million - $2.82 Million	-43,624 Reduced 75.65%	14,042 $814,000
Q2 2023 Feb 22, 2024	BUY	$63.71 - $70.74 $734,066 - $815,066	11,522 Added 39.7%	40,543 $2.59 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3.07 Million - $3.41 Million	48,199 Added 509.13%	57,666 $3.69 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $304,565 - $345,446	4,635 Added 95.92%	9,467 $656,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $330,895 - $391,826	4,832 New	4,832 $347,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $1.42 Million - $1.56 Million	-19,526 Reduced 64.44%	10,774 $830,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $394,271 - $472,766	6,413 Added 26.85%	30,300 $2.21 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.28 Million - $1.49 Million	23,887 New	23,887 $1.49 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $2.11 Million - $2.47 Million	-35,700 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $2.8 Million - $3.05 Million	-45,239 Reduced 55.89%	35,700 $2.39 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $4.35 Million - $4.9 Million	73,375 Added 970.06%	80,939 $5.11 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $828,915 - $939,313	-14,356 Reduced 65.49%	7,564 $469,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $1.26 Million - $1.39 Million	21,920 New	21,920 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.04 Million - $1.35 Million	-21,336 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $148,681 - $167,701	2,694 Added 14.45%	21,336 $1.33 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $302,876 - $377,502	5,994 Added 47.39%	18,642 $1.03 Million
Q1 2018 Aug 14, 2018	BUY	$59.92 - $68.98 $757,868 - $872,459	12,648 New	12,648 $800,000
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $826,236 - $951,165	-13,789 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $826,512 - $901,111	13,789	13,789 $845,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Account

Teza Capital Management LLC Bristol Myers Squibb CO Transaction History